Catyalyst Pharmaceutical Partners (CPRX) Posts Q3 Loss of 5c/Sh.
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.40 --0%
EPS Growth %: -30.9%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -30.9%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q3 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- Kroger meets earnings expectations, revenue tops estimates
- Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
